Category: Alzheimer’s Research

On June 7, 2021 the FDA approved a drug called Aducabanumab which is manufactured by Biogen. It will be sold under the name Aduhelm. It is a monthly intravenous infusion intended to slow cognitive decline in people with mild memory and thinking problems. It is the first approved treatment to attack the disease process of … Continue reading Am I Excited About the New Alzheimer’s Drug…..Am I Going to Take It?

The only potential Alzheimer’s drug to showed hope did not fair well at the last FDA meeting, but I am still hopeful. Read why.